Affiliation:
1. Field Research Section, Diabetes and Arthritis Program, National Center for Chronic Disease Control, U.S. Public Health Service 745 Massachusetts Avenue, Boston, Massachusetts
Abstract
The enzymes of the sorbitol pathway, aldose reductase and sorbitol dehydrogenase, were investigated in sciatic nerve and spinal cord. The substrate specificities of spinal cord aldose reductase indicates that it is a variant of TPN L-hexonate dehydrogenase which possesses poor polyol forming ability. In contrast, the cauda equina and sciatic nerve aldose reductase have a true aldose reductase with considerable polyol forming ability. The distribution of the latter enzyme is associated with the presence of Schwann cells. Wallerian degeneration experiments are compatible with the localization of true aldose reductase in the Schwann cell and sorbitol dehydrogenase in the axon. There was no change in the levels of sorbitol dehydrogenase in diabetic nerves, a 30 per cent decrease occurred in the aldose reductase content. This decrease suggests a metabolic abnormality of the Sehwann cell, possibly resulting from alrered cellular integrity, which may have important implication for the otiology of diabetic neuropathy.
Publisher
American Diabetes Association
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Cited by
193 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献